Topics

Adult-type Diffuse Gliomas | Treatment | Immunotherapy | CAR-T-Cells

Home > Publications > Topics > Adult-type Diffuse Gliomas > Treatment > Immunotherapy > CAR-T-Cells

Li X, Shang X, Liu J, Zhang Y, Jia X, Li H, Wang Y, Gao J, Ma X, Zhang X, Rong X, Gan W, Zhang Y, Chen J, Wang L, Bao Z, He L, Yan X, Liu Y, Shao J, Xiao Z, Wang Z, Zhu H, Wang Z, Wu Y, Huang Y.
Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial.
Nat Commun. 2026 Jan 6. doi: 10.1038/s41467-025-68112-6. PMID: 41495049. Interventional study. ˍ